The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
in 2010 Purdue rolls out this reformulated version of Oxycontin that they've worked on for years it's basically you can't crush it it's sort of it's like a Gummy Bear you know if you if you try and break it up it just kind of goes chewy and gummy on you um there's an interesting backstory there questions about why it took so long to roll that out there's an interesting aspect of the timing which is that the original patents on oxycontin were about to run out
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.